| Tretinoin | Approved Investigational Nutraceutical | CTSD | 1509 |
upregulated | Tretinoin results in increased expression of CTSD mRNA | 11p15.5 | |
| Tretinoin | Approved Investigational Nutraceutical | CTSF | 8722 |
upregulated | Tretinoin results in increased expression of CTSF mRNA | 11q13.2 | |
| Tretinoin | Approved Investigational Nutraceutical | CTSG | 1511 |
downregulated | Tretinoin results in decreased expression of CTSG mRNA | 14q12 | |
| Tretinoin | Approved Investigational Nutraceutical | CTSH | 1512 |
downregulated | Tretinoin results in decreased expression of CTSH mRNA | 15q25.1 | |
| Tretinoin | Approved Investigational Nutraceutical | CTSK | 1513 |
upregulated | Tretinoin results in increased expression of CTSK mRNA | 1q21.3 | |
| Tretinoin | Approved Investigational Nutraceutical | CTSS | 1520 |
upregulated | Tretinoin results in increased expression of CTSS mRNA | 1q21.3 | |
| Tretinoin | Approved Investigational Nutraceutical | CTSV | 1515 |
downregulated | Tretinoin results in decreased expression of CTSV mRNA | 9q22.33 | |
| Tretinoin | Approved Investigational Nutraceutical | CTTNBP2 | 83992 |
downregulated | Tretinoin results in decreased expression of CTTNBP2 mRNA | 7q31.31 | |
| Tretinoin | Approved Investigational Nutraceutical | CUL1 | 8454 |
downregulated | Tretinoin results in decreased expression of CUL1 mRNA | 7q36.1 | |
| Tretinoin | Approved Investigational Nutraceutical | CUL4A | 8451 |
downregulated | Tretinoin results in decreased expression of CUL4A mRNA | 13q34 | |
| Tretinoin | Approved Investigational Nutraceutical | CUL5 | 8065 |
downregulated | Tretinoin results in decreased expression of CUL5 mRNA | 11q22.3 | |
| Tretinoin | Approved Investigational Nutraceutical | CUZD1 | 50624 |
downregulated | Tretinoin results in decreased expression of CUZD1 mRNA | 10q26.13 | |
| Tretinoin | Approved Investigational Nutraceutical | CX3CL1 | 6376 |
downregulated | Tretinoin results in decreased expression of CX3CL1 mRNA | 16q21 | |
| Tretinoin | Approved Investigational Nutraceutical | CXCL1 | 2919 |
downregulated | Tretinoin metabolite results in decreased expression of CXCL1 mRNA | 4q13.3 | |
| Tretinoin | Approved Investigational Nutraceutical | CXCL1 | 2919 |
downregulated | Tretinoin results in decreased expression of CXCL1 mRNA | 4q13.3 | |
| Tretinoin | Approved Investigational Nutraceutical | CXCL11 | 6373 |
downregulated | Tretinoin results in decreased expression of CXCL11 mRNA | 4q21.1 | |
| Tretinoin | Approved Investigational Nutraceutical | CXCL12 | 6387 |
upregulated | Tretinoin results in increased expression of CXCL12 mRNA | 10q11.21 | |
| Tretinoin | Approved Investigational Nutraceutical | CXCL14 | 9547 |
downregulated | Tretinoin results in decreased expression of CXCL14 mRNA | 5q31.1 | |
| Tretinoin | Approved Investigational Nutraceutical | CXCL16 | 58191 |
upregulated | Tretinoin results in increased expression of CXCL16 mRNA | 17p13.2 | |
| Tretinoin | Approved Investigational Nutraceutical | CXCL8 | 3576 |
upregulated | Tretinoin results in increased expression of CXCL8 mRNA | 4q13.3 | |
| Tretinoin | Approved Investigational Nutraceutical | CXCR1 | 3577 |
upregulated | Tretinoin results in increased expression of CXCR1 mRNA | 2q35 | |
| Tretinoin | Approved Investigational Nutraceutical | CXCR4 | 7852 |
downregulated | Tretinoin results in decreased expression of CXCR4 mRNA | 2q22.1 | |
| Tretinoin | Approved Investigational Nutraceutical | CXCR5 | 643 |
upregulated | Tretinoin results in increased expression of CXCR5 mRNA | 11q23.3 | |
| Tretinoin | Approved Investigational Nutraceutical | CXXC5 | 51523 |
upregulated | Tretinoin results in increased expression of CXXC5 mRNA | 5q31.2 | |
| Tretinoin | Approved Investigational Nutraceutical | CYB561 | 1534 |
upregulated | Tretinoin results in increased expression of CYB561 mRNA | 17q23.3 | |